Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 873 | 8,077 | -3,666 | -10,277 | -8,654 |
| Depreciation Amortization | 251 | 168 | 85 | 392 | 302 |
| Accounts receivable | -2,525 | -1,911 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,070 | 4,200 | 1,013 | -2,227 | -1,982 |
| Other Working Capital | -13,176 | -10,195 | 418 | -775 | -1,401 |
| Other Operating Activity | 6,222 | -985 | -927 | 170 | 1,518 |
| Operating Cash Flow | $-7,285 | $-646 | $-3,077 | $-12,717 | $-10,217 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -340 | -87 | -9 | -164 | -155 |
| Investing Cash Flow | $-340 | $-87 | $-9 | $-164 | $-155 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 9,438 | 9,510 |
| Other Financing Activity | -37 | -22 | -22 | 456 | -444 |
| Financing Cash Flow | $-37 | $-22 | $-22 | $9,894 | $9,066 |
| Beginning Cash Position | 14,430 | 14,430 | 14,430 | 17,417 | 17,417 |
| End Cash Position | 6,768 | 13,675 | 11,322 | 14,430 | 16,111 |
| Net Cash Flow | $-7,662 | $-755 | $-3,108 | $-2,987 | $-1,306 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,285 | -646 | -3,077 | -12,717 | -10,217 |
| Capital Expenditure | -340 | -87 | -9 | -164 | -155 |
| Free Cash Flow | -7,625 | -733 | -3,086 | -12,881 | -10,372 |